Abbott Laboratories, of Abbott Park, Ill., received FDA clearancefor its gonorrhea test that uses ligase chain reaction technology. Thetest is designed to be used on the company's LCx Probe System.
Biopool International Inc., of Ventura, Calif., received FDAmarketing approval for its Lupus Anticoagulant (LA) PositiveControl Plasma for use in quality-control monitoring of assays forLA.
Metasyn Inc., of Cambridge, Mass., completed a fourth round offinancing totaling $5.1 million. The company is developing injectablecontrast enhancing agents for magnetic resonance imaging.
Molecular Biosystems Inc., of San Diego, grossed $30 million in apublic offering of 3.6 million shares. The company developsultrasound contrast agents for medical imaging.
Roche Molecular Systems, of Branchburg, N.J., received FDAapproval to market Amplicor HIV-1 Monitor, the first approved testfor measuring HIV-1 RNA in the blood. Using PCR technology, thetest uses a amplification technique to quantitate viral load. The test isintended as an indicator of disease prognosis.
(c) 1997 American Health Consultants. All rights reserved.